Publications by authors named "Albert J Wong"

27Publications

Generation of regulable EGFRvIII targeted chimeric antigen receptor T cells for adoptive cell therapy of glioblastoma.

Biochem Biophys Res Commun 2018 12 6;507(1-4):59-66. Epub 2018 Nov 6.

Biotherapy Center, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450003, China; Stem Cell Research Center, People's Hospital of Henan Province, Zhengzhou University, Zhengzhou, 450003, China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0006291X183232
Publisher Site
http://dx.doi.org/10.1016/j.bbrc.2018.10.151DOI Listing
December 2018

Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody.

Artif Cells Nanomed Biotechnol 2018 Feb 15;46(1):89-94. Epub 2017 Mar 15.

a Department of Medical Biochemistry, Faculty of Medicine , Tehran University of Medical Sciences , Tehran , Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21691401.2017.1296847DOI Listing
February 2018

Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III.

Cancer Res 2014 Feb 23;74(4):1238-49. Epub 2013 Dec 23.

Authors' Affiliations: Brain Tumor Research Laboratories, Program in Cancer Biology, Stanford University Medical Center, Stanford; Department of Pathology, Stanford University Medical Center, Stanford; Institute of Stem Cell Biology and Regenerative Medicine, Stanford University Medical Center, Stanford; Department of Neurosurgery, Stanford University School of Medicine, Stanford; Veterans Affairs Palo Alto Health Care System, Palo Alto, California; Department of Physiology and Pharmacology, Institute for Biomedical Research, School of Medicine, University of Salamanca, Salamanca, Spain; Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, Massachusetts; and Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou, Henan, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-1407DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661963PMC
February 2014

Epidermal growth factor receptor variant III contributes to cancer stem cell phenotypes in invasive breast carcinoma.

Cancer Res 2012 May 14;72(10):2657-71. Epub 2012 Mar 14.

Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-2656DOI Listing
May 2012

Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas.

J Neurooncol 2012 Jul 2;108(3):395-402. Epub 2012 Mar 2.

Department of Neurosurgery, Stanford University Medical Center, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-0842-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368992PMC
July 2012

Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas.

Expert Rev Vaccines 2012 Feb;11(2):133-44

Stanford University, 1201 Welch Road, MSLS P105, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erv.11.177DOI Listing
February 2012

Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma.

Proc Natl Acad Sci U S A 2011 Mar 1;108(11):4453-8. Epub 2011 Mar 1.

Department of Neurology, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University Medical Center, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1101657108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060250PMC
March 2011

Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.

Curr Opin Mol Ther 2010 Dec;12(6):741-54

Stanford University, 300 Pasteur Drive, Edwards R213, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
December 2010

Measuring the constitutive activation of c-Jun N-terminal kinase isoforms.

Methods Enzymol 2010 ;484:531-48

Department of Neurosurgery, Cancer Biology Program, Stanford University Medical Center, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-12-381298-8.00026-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079000PMC
February 2011

Development of an EGFRvIII specific recombinant antibody.

BMC Biotechnol 2010 Oct 7;10:72. Epub 2010 Oct 7.

Brain Tumor Research Laboratories, Department of Neurosurgery, and Program in Cancer Biology, Stanford University Medical Center, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6750-10-72DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959087PMC
October 2010

Pineal parenchymal tumor of intermediate differentiation: clinicopathological report and analysis of epidermal growth factor receptor variant III expression.

Neurosurgery 2010 May;66(5):963-8; discussion 968

Department of Neurosurgery, Stanford University School of Medicine, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/01.NEU.0000367726.49003.F1DOI Listing
May 2010

The epidermal growth factor variant III peptide vaccine for treatment of malignant gliomas.

Neurosurg Clin N Am 2010 Jan;21(1):87-93

Department of Neurosurgery, Stanford University School of Medicine, 300 Pasteur Drive, Edwards Building Room 213, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nec.2009.08.004DOI Listing
January 2010

Constitutive activity of JNK2 alpha2 is dependent on a unique mechanism of MAPK activation.

J Biol Chem 2008 Dec 21;283(50):34935-45. Epub 2008 Oct 21.

Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M804970200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596385PMC
December 2008

EGF receptor variant III as a target antigen for tumor immunotherapy.

Expert Rev Vaccines 2008 Sep;7(7):977-85

Department of Neurosurgery, Stanford University School of Medicine, 300 Pasteur Drive, Edwards Building Room 213, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14760584.7.7.977DOI Listing
September 2008

The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation.

J Biol Chem 2007 Mar 17;282(11):7758-69. Epub 2006 Dec 17.

Centre de Recherche du Centre Hospitalier de l'Université de Montréal/Institut du Cancer de Montréal and Département de Médecine de l'Université de Montréal, Montréal, Québec H2L 4M1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M611327200DOI Listing
March 2007

c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells.

Cancer Res 2006 Oct;66(20):10024-31

Department of Neurosurgery, Stanford University Medical Center, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-0136DOI Listing
October 2006

Beta1 integrins modulate cell adhesion by regulating insulin-like growth factor-II levels in the microenvironment.

Cancer Res 2006 Jan;66(1):331-42

Department of Cancer Biology and the Cancer Center, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-2588DOI Listing
January 2006

Identification of a specific domain responsible for JNK2alpha2 autophosphorylation.

J Biol Chem 2005 Mar 6;280(11):9913-20. Epub 2005 Jan 6.

Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, 233 S. 10th St., Philadelphia, Pennsylvania 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M412165200DOI Listing
March 2005

Role of the Grb2-associated binder 1/SHP-2 interaction in cell growth and transformation.

Cancer Res 2004 Mar;64(6):2007-15

Department of Microbiology and Immunology, The Kimmel Cancer Institute, Thomas Jefferson University, 233 South 10th Street, 1002 BLSB, Philadelphia, PA 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.can-03-2886DOI Listing
March 2004

Gab1 is an integrator of cell death versus cell survival signals in oxidative stress.

Mol Cell Biol 2003 Jul;23(13):4471-84

Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC164844PMC
http://dx.doi.org/10.1128/mcb.23.13.4471-4484.2003DOI Listing
July 2003

Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors.

Cancer Res 2003 Jan;63(1):250-5

Department of Microbiology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

View Article

Download full-text PDF

Source
January 2003

Elevated JNK activation contributes to the pathogenesis of human brain tumors.

Oncogene 2002 Aug;21(33):5038-46

The Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, PA 19107, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/1205593
Publisher Site
http://dx.doi.org/10.1038/sj.onc.1205593DOI Listing
August 2002

Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors.

Am J Pathol 2002 Feb;160(2):441-7

Department of Microbiology and Immunology, Kimmel Cancer Institute, BLSB 2002, Thomas Jefferson University, 233 S. 10th St., Philadelphia, PA 19107, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1850643PMC
http://dx.doi.org/10.1016/S0002-9440(10)64863-8DOI Listing
February 2002